Global Active Pharmaceutical Ingredients Market 2023-2027

Quick Summary:

Emerging trends in the global active pharmaceutical ingredients market reveal that the market is poised for significant growth. The evolving manufacturing scenario in developing countries, the increasing number of type II drug master files, and the rising need to focus on core competencies are driving rapid advancements in this sector.

In the market segmentation, two main manufacturing types are leading the sector: captive and contract APIs. The market is driven by both innovative and generic APIs, highlighting the diversity of opportunities available. Geographically, the active pharmaceutical ingredients market spans across Asia, North America, Europe and the Rest of the World, ensuring a global reach and numerous market entry points.

This report is critical for those desiring a complete analysis of the active pharmaceutical ingredients market, forecasting future trends, industry challenges and offering a robust vendor analysis. The study is backed by extensive research, synthesizing information from key industry influencers and providing a dependable, comprehensive understanding of the market growth and its trajectory.

The active pharmaceutical ingredients market is forecast to grow by USD 88.74 bn during 2022-2027, accelerating at a CAGR of 7.24% during the forecast period. The report on the active pharmaceutical ingredients market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by evolving API manufacturing scenario in developing countries, the increasing number of type II drug master files (DFMS), and the growing need to focus on core competencies.

The active pharmaceutical ingredients market is segmented as below:

By Manufacturing Type

Captive APIs
Contract APIs

By Type

Innovative APIs
Generic APIs

By Geography

Asia
North America
Europe
Rest of World (ROW)

This study identifies the paradigm shift in API manufacturing as one of the prime reasons driving the active pharmaceutical ingredients market growth during the next few years. Also, increasing patent expiries and increasing geriatric population will lead to sizable demand in the market.

The report on the active pharmaceutical ingredients market covers the following areas:

Active pharmaceutical ingredients market sizing
Active pharmaceutical ingredients market forecast
Active pharmaceutical ingredients market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredients market vendors that include AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc. Also, the active pharmaceutical ingredients market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global active pharmaceutical ingredients market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global active pharmaceutical ingredients market 2017 - 2021 ($ billion)
4.2 By Manufacturing type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - By Manufacturing type Segment 2017 - 2021 ($ billion)
4.3 By types Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - By types Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Manufacturing Type

6.1 Market segments
Exhibit 30: Chart on Manufacturing Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Manufacturing Type - Market share 2022-2027 (%)
6.2 Comparison by Manufacturing Type
Exhibit 32: Chart on Comparison by Manufacturing Type
Exhibit 33: Data Table on Comparison by Manufacturing Type
6.3 Captive APIs - Market size and forecast 2022-2027
Exhibit 34: Chart on Captive APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Captive APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Captive APIs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Captive APIs - Year-over-year growth 2022-2027 (%)
6.4 Contract APIs - Market size and forecast 2022-2027
Exhibit 38: Chart on Contract APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Contract APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Contract APIs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Contract APIs - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Manufacturing Type
Exhibit 42: Market opportunity by Manufacturing Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Manufacturing Type ($ billion)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022-2027 (%)
Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Innovative APIs - Market size and forecast 2022-2027
Exhibit 48: Chart on Innovative APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Data Table on Innovative APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 50: Chart on Innovative APIs - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Innovative APIs - Year-over-year growth 2022-2027 (%)
7.4 Generic APIs - Market size and forecast 2022-2027
Exhibit 52: Chart on Generic APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Generic APIs - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Generic APIs - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Generic APIs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 56: Market opportunity by Type ($ billion)
Exhibit 57: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share by geography 2022-2027 (%)
Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 63: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 China - Market size and forecast 2022-2027
Exhibit 79: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on China - Year-over-year growth 2022-2027 (%)
9.8 India - Market size and forecast 2022-2027
Exhibit 83: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on India - Year-over-year growth 2022-2027 (%)
9.9 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 99: Market opportunity by geography ($ billion)
Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 107: AbbVie Inc. - Overview
Exhibit 108: AbbVie Inc. - Product / Service
Exhibit 109: AbbVie Inc. - Key news
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Amneal Pharmaceuticals Inc.
Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
12.5 Aurobindo Pharma Ltd.
Exhibit 116: Aurobindo Pharma Ltd. - Overview
Exhibit 117: Aurobindo Pharma Ltd. - Product / Service
Exhibit 118: Aurobindo Pharma Ltd. - Key offerings
12.6 Cadila Pharmaceuticals Ltd.
Exhibit 119: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 120: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 121: Cadila Pharmaceuticals Ltd. - Key offerings
12.7 Cipla Ltd.
Exhibit 122: Cipla Ltd. - Overview
Exhibit 123: Cipla Ltd. - Business segments
Exhibit 124: Cipla Ltd. - Key news
Exhibit 125: Cipla Ltd. - Key offerings
Exhibit 126: Cipla Ltd. - Segment focus
12.8 Dr Reddys Laboratories Ltd.
Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 131: GlaxoSmithKline Plc - Overview
Exhibit 132: GlaxoSmithKline Plc - Business segments
Exhibit 133: GlaxoSmithKline Plc - Key offerings
Exhibit 134: GlaxoSmithKline Plc - Segment focus
12.10 Koninklijke DSM NV
Exhibit 135: Koninklijke DSM NV - Overview
Exhibit 136: Koninklijke DSM NV - Business segments
Exhibit 137: Koninklijke DSM NV - Key news
Exhibit 138: Koninklijke DSM NV - Key offerings
Exhibit 139: Koninklijke DSM NV - Segment focus
12.11 Lupin Ltd.
Exhibit 140: Lupin Ltd. - Overview
Exhibit 141: Lupin Ltd. - Product / Service
Exhibit 142: Lupin Ltd. - Key news
Exhibit 143: Lupin Ltd. - Key offerings
12.12 Novartis AG
Exhibit 144: Novartis AG - Overview
Exhibit 145: Novartis AG - Business segments
Exhibit 146: Novartis AG - Key offerings
Exhibit 147: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 148: Pfizer Inc. - Overview
Exhibit 149: Pfizer Inc. - Product / Service
Exhibit 150: Pfizer Inc. - Key news
Exhibit 151: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 152: Sanofi SA - Overview
Exhibit 153: Sanofi SA - Business segments
Exhibit 154: Sanofi SA - Key news
Exhibit 155: Sanofi SA - Key offerings
Exhibit 156: Sanofi SA - Segment focus
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 157: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 158: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 159: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 165: Viatris Inc. - Overview
Exhibit 166: Viatris Inc. - Business segments
Exhibit 167: Viatris Inc. - Key offerings
Exhibit 168: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global active pharmaceutical ingredients market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - By Manufacturing type Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - By types Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Manufacturing Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Manufacturing Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Manufacturing Type
Exhibits 33: Data Table on Comparison by Manufacturing Type
Exhibits 34: Chart on Captive APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Captive APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Captive APIs - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Captive APIs - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Contract APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Contract APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Contract APIs - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Contract APIs - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Manufacturing Type ($ billion)
Exhibits 43: Data Table on Market opportunity by Manufacturing Type ($ billion)
Exhibits 44: Chart on Type - Market share 2022-2027 (%)
Exhibits 45: Data Table on Type - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Type
Exhibits 47: Data Table on Comparison by Type
Exhibits 48: Chart on Innovative APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 49: Data Table on Innovative APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 50: Chart on Innovative APIs - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Innovative APIs - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Generic APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 53: Data Table on Generic APIs - Market size and forecast 2022-2027 ($ billion)
Exhibits 54: Chart on Generic APIs - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Generic APIs - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Type ($ billion)
Exhibits 57: Data Table on Market opportunity by Type ($ billion)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share by geography 2022-2027 (%)
Exhibits 60: Data Table on Market share by geography 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 64: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 80: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 81: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits 84: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits 85: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity by geography ($ billion)
Exhibits 100: Data Tables on Market opportunity by geography ($ billion)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: AbbVie Inc. - Overview
Exhibits 108: AbbVie Inc. - Product / Service
Exhibits 109: AbbVie Inc. - Key news
Exhibits 110: AbbVie Inc. - Key offerings
Exhibits 111: Amneal Pharmaceuticals Inc. - Overview
Exhibits 112: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 113: Amneal Pharmaceuticals Inc. - Key news
Exhibits 114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 115: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 116: Aurobindo Pharma Ltd. - Overview
Exhibits 117: Aurobindo Pharma Ltd. - Product / Service
Exhibits 118: Aurobindo Pharma Ltd. - Key offerings
Exhibits 119: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 120: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 121: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 122: Cipla Ltd. - Overview
Exhibits 123: Cipla Ltd. - Business segments
Exhibits 124: Cipla Ltd. - Key news
Exhibits 125: Cipla Ltd. - Key offerings
Exhibits 126: Cipla Ltd. - Segment focus
Exhibits 127: Dr Reddys Laboratories Ltd. - Overview
Exhibits 128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 131: GlaxoSmithKline Plc - Overview
Exhibits 132: GlaxoSmithKline Plc - Business segments
Exhibits 133: GlaxoSmithKline Plc - Key offerings
Exhibits 134: GlaxoSmithKline Plc - Segment focus
Exhibits 135: Koninklijke DSM NV - Overview
Exhibits 136: Koninklijke DSM NV - Business segments
Exhibits 137: Koninklijke DSM NV - Key news
Exhibits 138: Koninklijke DSM NV - Key offerings
Exhibits 139: Koninklijke DSM NV - Segment focus
Exhibits 140: Lupin Ltd. - Overview
Exhibits 141: Lupin Ltd. - Product / Service
Exhibits 142: Lupin Ltd. - Key news
Exhibits 143: Lupin Ltd. - Key offerings
Exhibits 144: Novartis AG - Overview
Exhibits 145: Novartis AG - Business segments
Exhibits 146: Novartis AG - Key offerings
Exhibits 147: Novartis AG - Segment focus
Exhibits 148: Pfizer Inc. - Overview
Exhibits 149: Pfizer Inc. - Product / Service
Exhibits 150: Pfizer Inc. - Key news
Exhibits 151: Pfizer Inc. - Key offerings
Exhibits 152: Sanofi SA - Overview
Exhibits 153: Sanofi SA - Business segments
Exhibits 154: Sanofi SA - Key news
Exhibits 155: Sanofi SA - Key offerings
Exhibits 156: Sanofi SA - Segment focus
Exhibits 157: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 158: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 159: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 165: Viatris Inc. - Overview
Exhibits 166: Viatris Inc. - Business segments
Exhibits 167: Viatris Inc. - Key offerings
Exhibits 168: Viatris Inc. - Segment focus
Exhibits 169: Inclusions checklist
Exhibits 170: Exclusions checklist
Exhibits 171: Currency conversion rates for US$
Exhibits 172: Research methodology
Exhibits 173: Validation techniques employed for market sizing
Exhibits 174: Information sources
Exhibits 175: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global active pharmaceutical ingredients market: AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is paradigm shift in API manufacturing.`

According to the report, one of the major drivers for this market is the evolving API manufacturing scenario in developing countries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.